Price $198.53 |
Market Cap
16.29B
|
Sector Health Care |
Div. Growth
8.30%
|
|
P/E
41.3
|
P/B
4.2
|
P/S
5.24
|
Dividend %
0.80%
|
|
P/CF
-
|
P/FCF
51.8
|
Op. Cash Flow
689.6K
|
FCF
3.6
|
|
Op. Margin
17.60%
|
Net Margin
12.80%
|
ROE
10.70%
|
ROI
7.70%
|
|
ROA
6.60%
|
EPS Growth
-3.00%
|
Current Ratio
2.1
|
Debt/Equity
42.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $7.74 | - | - | 121.9M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.45 | - | - | 47.1M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $13.50 | - | - | 55.3M | Strong Buy |
| Novavax, Inc. (NVAX) | $209.68 | - | - | 11.17B | Strong Buy |
| Natus Medical Inc (NTUS) | $27.49 | - | - | 906.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
